Application no. and date | 15739327.3 (espacenet) (Federated) (European Patent Register), 20150429 | Patent/reg. no. and date | DK/EP 3137595, 20190313 | Publication date | 20170308 | Priority no. and date | US 201461985589 P, 20140429, US 201461994310 P, 20140516 | EP pub. no. and date |
EP 3137595 20170308 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | SH/GP/158823 | Inventor | LAUX, Holger, c/o Novartis Pharma AG Postfach
CH-4002 Basel, CH, ROMAND, Sandrine, c/o Novartis Pharma AG Postfach
CH-4002 Basel, CH, BODENDORF, Ursula, c/o Novartis Pharma AG Postfach
CH-4002 Basel, CH | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | C12N 15/67 (2006.01) , C12N 15/85 (2006.01) , C12N 15/87 (2006.01) , C12N 5/00 (2006.01) , C12N 5/071 (2010.01) | Title | Hidtil ukendte vertebratceller og fremgangsmåder til rekombinant ekspression af et polypeptid af interesse | Int. application no. | IB2015053110 | Int. publication no. | WO2015166427 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|